The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

American Journal of Transplantation - Tập 17 Số 1 - Trang 28-41 - 2017
Alexandre Loupy1, Mark Haas2, Kim Solez3, Lorraine C. Racusen4, Denis Glotz5, Daniel Serón6, Brian J. Nankivell7, Robert B. Colvin8, Marjan Afrouzian9, Enver Akalin10, Nada Alachkar11, Serena M. Bagnasco4, Jan U. Becker12, Lynn D. Cornell13, Cinthia B. Drachenberg14, Duska Dragun15, A J Demetris16, Ian W. Gibson17, Edward S. Kraus11, Carmen Lefaucheur5, Christophe Legendre1, Helen Liapis18, Thangamani Muthukumar19, Volker Nickeleit20, Babak J. Orandi11, Walter D. Park13, Marion Rabant1, Parmjeet Randhawa21, Elaine F. Reed22, Candice Roufosse23, Surya V. Seshan24, Banu Sis3, Harsharan K. Singh20, Carrie A. Schinstock25, Anat R. Tambur26, Adriana Zeevi27, Michael Mengel3
1Paris Translational Research Center for Organ Transplantation INSERM U970, Necker Hospital University Paris Descartes, Paris, France
2Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
3Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada
4Department of Laboratory Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
5Paris Translational Research Center for Organ Transplantation & Department of Nephrology and Transplantation, Hopital Saint Louis, Université Paris VII and INSERM U 1160, Paris, France
6Nephrology Department, Hospital Vall d’Hebron, Autonomous University of Barcelona, Barcelona, Spain
7Department of Renal Medicine, Westmead Hospital, Sydney, Australia
8Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA
9Departments of Pathology & Internal Medicine, University of Texas Medical Branch, Galveston, TX
10Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
11Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
12Institute of Pathology, University Hospital of Cologne, Cologne, Germany
13Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
14University of Maryland School of Medicine, Baltimore, Md
15Berlin Institute of Health and Department of Nephrology and Critical Care Medicine, Charité Universitätsmedizin, Berlin, Germany
16Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands
17Department of Pathology, University of Manitoba, Winnipeg, Canada
18Department of Pathology & Immunology, Washington University, St. Louis, MO
19Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY
20Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC
21Division of Transplantation Pathology, The Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA
22Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA
23Department of Cellular Pathology, Hammersmith Hospital, London, UK.
24Department of Pathology, Weill Cornell Medicine, New York, NY
25Division of Nephrology, Mayo Clinic, Rochester, MN
26Comprehensive Transplant Center, Transplant Immunology Laboratory, Northwestern University, Chicago, IL
27University of Pittsburgh Medical Center, Pittsburgh, PA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Haas, 2014, Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, 14, 272, 10.1111/ajt.12590

Sis, 2010, Banff ‘09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups, Am J Transplant, 10, 464, 10.1111/j.1600-6143.2009.02987.x

Sis, 2015, Isolated endarteritis and kidney transplant survival: A multicenter collaborative study, J Am Soc Nephrol, 26, 1216, 10.1681/ASN.2014020157

Mengel, 2013, Banff initiative for quality assurance in transplantation (BIFQUIT): Reproducibility of C4d immunohistochemistry in kidney allografts, Am J Transplant, 13, 1235, 10.1111/ajt.12193

Farris, 2014, Banff fibrosis study: Multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies, Am J Transplant, 14, 897, 10.1111/ajt.12641

Liapis, 2016, Banff histopathological consensus criteria for pre-implantation kidney biopsies, Am J Transplant

Adam, 2014, Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): Reproducibility of polyomavirus immunohistochemistry in kidney allografts, Am J Transplant, 14, 2137, 10.1111/ajt.12794

Solez, 2015, Multibiomarker article gives a taste of what the era of regenerative medicine/tissue engineering pathology will be like, Crit Care Med, 43, e599, 10.1097/CCM.0000000000001293

Wiebe, 2015, Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody, Am J Transplant, 15, 2921, 10.1111/ajt.13347

Orandi, 2016, Survival benefit with kidney transplants from hla-incompatible live donors, N Engl J Med, 374, 940, 10.1056/NEJMoa1508380

Loupy, 2015, Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts, J Am Soc Nephrol, 26, 1721, 10.1681/ASN.2014040399

Tait, 2013, Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation, Transplantation, 95, 19, 10.1097/TP.0b013e31827a19cc

Chen, 2011, Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads, Hum Immunol, 72, 849, 10.1016/j.humimm.2011.07.001

Yabu, 2011, C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation, Transplantation, 91, 342, 10.1097/TP.0b013e318203fd26

Loupy, 2013, Complement-binding anti-HLA antibodies and kidney-allograft survival, N Engl J Med, 369, 1215, 10.1056/NEJMoa1302506

Sicard, 2015, Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss, J Am Soc Nephrol, 26, 457, 10.1681/ASN.2013101144

Susal, 2015, Association of kidney graft loss with de novo produced donor-specific and non-donor-specific HLA antibodies detected by single antigen testing, Transplantation, 99, 1976, 10.1097/TP.0000000000000672

Yamamoto, 2015, De novo anti-HLA DSA characteristics and subclinical antibody-mediated kidney allograft injury, Transplantation

Fichtner, 2016, Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients, Pediatr Nephrol, 31, 1157, 10.1007/s00467-016-3322-8

Bamoulid, 2016, Clinical outcome of patients with de novo C1q-binding donor-specific HLA antibodies after renal transplantation, Transplantation

O’Leary, 2015, Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation, Am J Transplant, 15, 1003, 10.1111/ajt.13153

Zeevi, 2013, Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients, J Heart Lung Transplant, 32, 98, 10.1016/j.healun.2012.09.021

Tambur, 2015, Assessing antibody strength: Comparison of MFI, C1q, and titer information, Am J Transplant, 15, 2421, 10.1111/ajt.13295

Lefaucheur, 2016, IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury, J Am Soc Nephrol, 27, 293, 10.1681/ASN.2014111120

Calp-Inal, 2016, The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation, Kidney Int, 89, 209, 10.1038/ki.2015.275

Dragun, 2005, Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection, N Engl J Med, 352, 558, 10.1056/NEJMoa035717

Reinsmoen, 2014, Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome, Transplantation, 97, 595, 10.1097/01.TP.0000436927.08026.a8

Zhang, 2016, The importance of non-HLA antibodies in transplantation, Nat Rev Nephrol, 12, 484, 10.1038/nrneph.2016.88

Hidalgo, 2010, NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvement in antibody-mediated rejection, Am J Transplant, 10, 1812, 10.1111/j.1600-6143.2010.03201.x

Gupta, 2016, Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies, Kidney Int, 89, 217, 10.1038/ki.2015.276

Nickeleit, 2002, Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications, J Am Soc Nephrol, 13, 242, 10.1681/ASN.V131242

Lefaucheur, 2013, Antibody-mediated vascular rejection of kidney allografts: A population-based study, Lancet, 381, 313, 10.1016/S0140-6736(12)61265-3

Haas, 2002, Acute renal allograft rejection with intimal arteritis: Histologic predictors of response to therapy and graft survival, Kidney Int, 61, 1516, 10.1046/j.1523-1755.2002.00254.x

Sellares, 2012, Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence, Am J Transplant, 12, 388, 10.1111/j.1600-6143.2011.03840.x

Kahwaji, 2014, Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab, Clin Transplant, 28, 546, 10.1111/ctr.12345

Kulkarni, 2016, Eculizumab therapy for chronic antibody-mediated injury in kidney transplant recipients: A pilot randomized controlled trial, Am J Transplant, 10.1093/med/9780198729426.003.0030

Lesage, 2015, Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy, Transplantation, 99, 69, 10.1097/TP.0000000000000310

Solez, 2008, Banff 07 classification of renal allograft pathology: Updates and future directions, Am J Transplant, 8, 753, 10.1111/j.1600-6143.2008.02159.x

Mengel, 2009, Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts, Am J Transplant, 9, 1859, 10.1111/j.1600-6143.2009.02727.x

Mannon, 2010, Inflammation in areas of tubular atrophy in kidney allograft biopsies: A potent predictor of allograft failure, Am J Transplant, 10, 2066, 10.1111/j.1600-6143.2010.03240.x

Hueso, 2010, Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection, Am J Pathol, 176, 1696, 10.2353/ajpath.2010.090411

Loupy, 2015, Determinants and outcomes of accelerated arteriosclerosis: Major impact of circulating antibodies, Circ Res, 117, 470, 10.1161/CIRCRESAHA.117.306340

Hirohashi, 2010, Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice, Am J Transplant, 10, 510, 10.1111/j.1600-6143.2009.02958.x

Sarwal, 2013, A common blood gene assay predates clinical and histological rejection in kidney and heart allografts, Clin Transpl, 241

Muthukumar, 2014, Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: Interrogation by urinary cell mRNA profiling, Transplant Rev, 28, 145, 10.1016/j.trre.2014.05.003

Halloran, 2010, An integrated view of molecular changes, histopathology and outcomes in kidney transplants, Am J Transplant, 10, 2223, 10.1111/j.1600-6143.2010.03268.x

Halloran, 2013, Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study, Am J Transplant, 13, 2352, 10.1111/ajt.12387

Halloran, 2013, Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: An international prospective study (INTERCOM), Am J Transplant, 13, 2865, 10.1111/ajt.12465

Halloran, 2014, Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: New insights from the Genome Canada studies of kidney transplant biopsies, Kidney Int, 85, 258, 10.1038/ki.2013.300

Loupy, 2014, Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection, J Am Soc Nephrol, 25, 2267, 10.1681/ASN.2013111149

Li, 2013, Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection, PLoS ONE, 8, e82153, 10.1371/journal.pone.0082153

Khatri, 2013, A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation, J Exp Med, 210, 2205, 10.1084/jem.20122709

Halloran, 2016, Molecular assessment of disease states in kidney transplant biopsy samples, Nat Rev Nephrol, 12, 534, 10.1038/nrneph.2016.85

Sis, 2009, Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining, Am J Transplant, 9, 2312, 10.1111/j.1600-6143.2009.02761.x

Hayde, 2014, Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies, Kidney Int, 86, 600, 10.1038/ki.2014.75

Halloran, 2015, The molecular phenotypes of rejection in kidney transplant biopsies, Curr Opin Organ Transplant, 20, 359, 10.1097/MOT.0000000000000193

Troxell, 2016, Allograft pancreas: Pale acinar nodules, Hum Pathol, 54, 127, 10.1016/j.humpath.2016.02.029

Chandraker, 2014, The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplant, Am J Transplant, 14, 1446, 10.1111/ajt.12715

Kanitakis, 2016, Capillary thrombosis in the skin: A pathologic hallmark of severe/chronic rejection of human vascularized composite tissue allografts?, Transplantation, 100, 954, 10.1097/TP.0000000000000882

Drachenberg, 2011, Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts—Updated Banff grading schema, Am J Transplant, 11, 1792, 10.1111/j.1600-6143.2011.03670.x

Drachenberg, 2008, Banff schema for grading pancreas allograft rejection: Working proposal by a multi-disciplinary international consensus panel, Am J Transplant, 8, 1237, 10.1111/j.1600-6143.2008.02212.x

Thông tin
Thông tin xuất bản

American Journal of Transplantation

Tập 17 Số 1

28-41

Thông tin tác giả